A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® Cream, 0.1% in the Topical Treatment of Acne Vulgaris
Clinical trial NCT03341910 · COMPLETED
Trial details
- NCT number
- NCT03341910
- Sponsor
- Dr. Reddy's Laboratories Limited
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-21
- Primary completion
- 2018-05-18
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.